FENNEC PHARMACEUTICALS INC. — Director's Dealing 2010

Aug 21, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ADHEREX TECHNOLOGIES INC (ADHXF)
CIK: 0001211583
Period of Report: 2010-08-18

Reporting Person: Raykov Rosty (Director, NA)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-08-18	Common Stock Options (right to buy)	$0.045	A	0	Acquired	2017-08-18	Common Stock (17493939)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares	1000000	Direct

Footnotes

F1: The options will vest 100% on the date reported above and were issued in AHX (TSX listed shares).

F2: In Canadian Dollars.